Total planned funding: $374,119,421
Allocations
Countries/Regions
Eswatini | $374,119,421 |
Organizational Types
Private Contractor | $105,560,162 |
University | $64,268,250 |
NGO | $61,589,293 |
Unknown | $58,015,272 |
Own Agency | $45,296,381 |
FBO | $14,025,751 |
Multi-lateral Agency | $11,887,332 |
Host Country Government Agency | $11,068,033 |
Other USG Agency | $2,408,947 |
Implementing Agency | $0 |
Program Areas
Care | $112,737,396 |
Treatment | $106,387,362 |
Prevention | $68,746,561 |
Governance and Systems | $32,778,276 |
Testing | $28,287,156 |
Management and Operations | $25,182,670 |
Budget Codes
HTXS: Treatment: Adult Treatment | $83,089,895 |
HBHC: Care: Adult Care and Support | $48,046,750 |
HKID: Care: Orphans and Vulnerable Children | $40,491,852 |
HVCT: Testing: HIV Testing and Counseling | $28,287,156 |
HVOP: Sexual Prevention: Other Sexual Prevention | $26,217,829 |
HVMS: Management and Operations | $25,182,670 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $24,469,497 |
HVTB: Care: TB/HIV | $15,562,871 |
HTXD: Treatment: ARV Drugs | $15,358,167 |
OHSS: Health Systems Strengthening | $15,129,382 |
HVSI: Strategic Information | $12,478,057 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,405,634 |
PDCS: Care: Pediatric Care and Support | $8,635,923 |
PDTX: Treatment: Pediatric Treatment | $7,939,300 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,796,844 |
HLAB: Laboratory Infrastructure | $5,170,837 |
HMBL: Biomedical Prevention: Blood Safety | $856,757 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$53,157,980
Countries/Regions
Pact, Inc.:
$44,450,508
Countries/Regions
Not Available:
$39,202,419
Countries/Regions
Chemonics International:
$28,867,459
Countries/Regions